Chronic Kidney FailureMBDialysisNCT07212972
Mineral Bone Disorder in Dialysis
An observational study of Chronic Kidney Failure and Chronic Kidney Disease-Mineral and Bone Disorder, run by Çanakkale Onsekiz Mart University at 1 site in Turkey (Türkiye).
Trial summary
This study was conducted with 167 dialysis patients at Erciyes University Faculty of Medicine, Department of Internal Medicine, Department of Nephrology, and Dialysis Unit, with the approval of the Ethics Committee of Erciyes University Medical Faculty (date: 25.09.2019, no: 2019/673). Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Chronic Kidney Failure, Chronic Kidney Disease-Mineral and Bone Disorder, Dialysis
- What is being tested?
- Hemodialysis or peritoneal Dialysis
- How many people
- 167 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 25 Sep 2019to 20 Jun 2020
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: This study was performed with dialysis patients from Erciyes University Hospital, Faculty of Medicine, Department of Internal Medicine, and Department of Nephrology, and Dialysis Unit
Who may be able to join
- Age ≥ 18 years,
- Diagnosed with chronic kidney disease (CKD) and undergoing dialysis treatment (hemodialysis or peritoneal dialysis)
- Availability of laboratory results within the last 6 months: serum calcium, phosphorus, parathormone, albumin, hemoglobin, blood urea nitrogen (BUN), creatinine, and dialysate calcium
- Patient consent to participate
Who cannot join
- Age < 18 years
- Patients not on dialysis treatment
- Missing or incomplete laboratory data
- History of malignancy, acute infection, or other systemic diseases interfering with mineral and bone metabolism
- Patients who did not provide consent or could not complete the questionnaire
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Erciyes University Hospital, Faculty of Medicine, Department of Internal Medicine, and Department of Nephrology, and Dialysis Unit
Kayseri
About this study
Official title: Mineral and Bone Disorder in Chronic Kidney Disease: A Comparative Analysis of Hemodialysis and Peritoneal Dialysis Modalities
This study was conducted with 167 dialysis patients at Erciyes University Faculty of Medicine, Department of Internal Medicine, Department of Nephrology, and Dialysis Unit, with the approval of the Ethics Committee of Erciyes University Medical Faculty (date: 25.09.2019, no: 2019/673).
Patients aged ≥18 years, undergoing dialysis treatment, and having available data on serum calcium, phosphorus, parathormone, albumin, hemoglobin, blood urea nitrogen (BUN), creatinine, and dialysate calcium levels within the last six months were included in the study.
- Conditions
- Chronic Kidney Failure, Chronic Kidney Disease-Mineral and Bone Disorder, Dialysis, Hemodialysis
- Being tested
- Hemodialysis or peritoneal Dialysis
- Medical subject headings
- Kidney Failure, Chronic, Chronic Kidney Disease-Mineral and Bone Disorder
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Hemodialysis or peritoneal DialysisOther
Hemodialysis or peritoneal Dialysis
| Study group | Role | What they receive |
|---|---|---|
| dialysis | 167 patients diagnosed with CKD and undergoing HD or PD were included in the study Receives: Other: Hemodialysis or peritoneal Dialysis |
What is being measured
The primary outcome is the main question the study is designed to answer.
Blood values
Serum levels of calcium, phosphorus, parathyroid hormone, albumin, hemoglobin, BUN, creatinine, and dialysate calcium
Measured: At the enrollment
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Oct 2025
- Study start25 Sep 2019
- Primary completion15 Apr 2020
- Study completion20 Jun 2020
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Chronic Kidney FailureStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Retrospective
- Enrolment
- 167 participants (actual)
Sponsor and investigators
- Lead sponsor
- Çanakkale Onsekiz Mart University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Şeyma Eroğlu, Çanakkale Onsekiz Mart University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07212972
- Sponsor's protocol ID
- TZ-B
- Acronym
- MBDialysis
- Status last verified
- May 2022
- First submitted
- 2 Oct 2025
- Last updated
- 8 Oct 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- Yes
- Individual data sharing
- Undecided: They can be request.
Study at a glance
From the registry record, last updated by the sponsor on 8 Oct 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Mineral and Bone Disorder in Chronic Kidney Disease: A Comparative Analysis of Hemodialysis and Peritoneal Dialysis Modalities
- ClinicalTrials.gov ID
- NCT07212972
- Acronym / sponsor ID
- MBDialysis / TZ-B
- Conditions
- Chronic Kidney Failure, Chronic Kidney Disease-Mineral and Bone Disorder, Dialysis, Hemodialysis
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 167 participants (actual)
- Lead sponsor
- Çanakkale Onsekiz Mart UniversityUniversity, hospital or other
- Study start
- 25 Sep 2019 (actual)
- Primary completion
- 15 Apr 2020 (actual)
- Study completion
- 20 Jun 2020 (actual)
- First posted
- 8 Oct 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study was conducted with 167 dialysis patients at Erciyes University Faculty of Medicine, Department of Internal Medicine, Department of Nephrology, and Dialysis Unit, with the approval of the Ethics Committee of Erciyes University Medical Faculty (date: 25.09.2019, no: 2019/673).
Patients aged ≥18 years, undergoing dialysis treatment, and having available data on serum calcium, phosphorus, parathormone, albumin, hemoglobin, blood urea nitrogen (BUN), creatinine, and dialysate calcium levels within the last six months were included in the study.
Study design
- Observational model
- Other
- Time perspective
- Retrospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| dialysis | – | Other: Hemodialysis or peritoneal Dialysis167 patients diagnosed with CKD and undergoing HD or PD were included in the study |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- This study was performed with dialysis patients from Erciyes University Hospital, Faculty of Medicine, Department of Internal Medicine, and Department of Nephrology, and Dialysis Unit
Key inclusion criteria (4 listed)
- Age ≥ 18 years,
- Diagnosed with chronic kidney disease (CKD) and undergoing dialysis treatment (hemodialysis or peritoneal dialysis)
- Availability of laboratory results within the last 6 months: serum calcium, phosphorus, parathormone, albumin, hemoglobin, blood urea nitrogen (BUN), creatinine, and dialysate calcium
- Patient consent to participate
Key exclusion criteria (5 listed)
- Age < 18 years
- Patients not on dialysis treatment
- Missing or incomplete laboratory data
- History of malignancy, acute infection, or other systemic diseases interfering with mineral and bone metabolism
- Patients who did not provide consent or could not complete the questionnaire
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Hemodialysis or peritoneal DialysisHemodialysis or peritoneal Dialysis | Other | dialysis |
Primary outcome
Blood values
Time frame: At the enrollment
Serum levels of calcium, phosphorus, parathyroid hormone, albumin, hemoglobin, BUN, creatinine, and dialysate calcium
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Oct 2025.
- Individual participant dataSharing planned: Undecided. They can be request.
Related trials for Chronic Kidney Failure
Recruiting
Post Market Study for VasQ, an External Support Implant for Arteriovenous Fistula
End Stage Renal Disease
RecruitingObservational study
A Natural History Study of Metabolic Sizing in Health and Disease
Metabolic Disorders, Cancer
Not yet recruiting
Manual Acupuncture for Intradialytic Nausea and Vomiting in Patients Undergoing Hemodialysis
Intradialytic Nausea and Vomiting, Chronic Kidney Disease
Not yet recruitingObservational study
Unmasking Diabetes in Dialysis With Continuous Glucose Monitoring
End Stage Kidney Disease (ESKD), Hyperglycaemia
RecruitingPhase 2
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
Diabetic Kidney Disease (DKD)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Chronic Kidney Failure and Chronic Kidney Disease-Mineral and Bone Disorder, run by Çanakkale Onsekiz Mart University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 8 Oct 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Blood values (time frame: At the enrollment). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Oct 2025.